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NO-sy~thase may represent a new therapeutic c_~t  tor the treatment 0l 
e~thal ia!  ~/Sl~n~mn 
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~ Coronary Vas~u!ar E I f~  of Pltysi~l Exen:iu and 
Dobutam!n~: Comparison of Physiologic and 
Pharmacologic StmSsOrS 
A. P~asad. G Zalos, WH Schenke, E. Amegash~e, AN Kffsiou, 
A.A. OuyyumL NHLBI, B.etttescla. MD~ USA 
A I ~  dubutamine (D) ~s rout~m~ly used as a surmrjate tot exemise, Ihere 
is often (tscor~mce belween exercise and O slmss tes~, ~ l ly  in pts 
with n~M Coronary a~lery disease (CAD). While physral exeeCtse causes 
myocardial ~:hemia by a com~natmn el mcrease in demand and el~'ardial 
coronary (EC) constnction, it is not known whether conslnct~on plays a role 
in D-induced ¢schem,& We hypothesized that the dispanty is due partly m 
the lack ot EC conslnclion during D stress. EC diameter were measured m 
response to exercise and D in 10 pts wdh CAD. D was gnmn intracorenary tic) 
(10 to 80 .ojmm) and mtrevenously (iv) (5 to 40 pg/Kg/mm) unld ether 
peak dose, or myocardial =schem~a. or the -ate-pressure product ach~d 
during exercise was reached. Finally. 100 ~g K: nltroglycenn (NTG) was 
g~ven. The rate-pressure product dunng ex..rctse and D was slmdar (P = 
NS). Exercise produced no overall change *o, EC diameter, whereas at the 
peak doses of D. there was significant vaso~dateon compared to baseline (5 
± 1% and 7 ~ 1%. ic and iv, both P ,: 0.02). Even segments that censtncted 
~th exermse ( -5  : 2==) ddated wi~ *c and N O (7 =: 2% and g ~ 2=~, P 
< 0.01 respectively). NTG dilated all EC segments (11 ~: 2=0, P < 001) 
The data suggests that with equivalent myocardial streSs, D causes dflabon. 
whereas exercise can ohe,, ~u~uit n constnctmn of EC segments m CAD. 
tod*catmg fundamental pathophysiolog~c d~fferences between mechamsms 
underlying myocardial ,schemia produced by physiologic and pharmocotog~c 
slressors. Thus. D stress may not be adequate for diagnosing mild CAD, and 
for evaluating the effects ot tremment on ischemia 
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[ -~  An Analysis of Percutaneous Transluminal Coronary 
Angioplasty Performed in California in 1995 
D.L. Brown. Umve~s~/ of California. San Diego Medical Center, San Diego 
CA. USA 
Background. The use of percutaneous transluminal coronary angioplasty 
(PTCA) continues to expand. ApDroxtmatoly one-third of all PTCA procedures 
in the United States are pedormed in Califon da. This study descnbes the 1995 
California in-hospital expenence with PTCA using a statewide administrative 
data base. 
Methods: Discharge abstracts for all patients undergoing PTCA at non-Fed- 
eral hospitals in California in 1995 were analyzed. 
Results: 154,193 PTCAs were pedormed. Mean age was 64.7 years 
and 66.2% were male. Acute myOCardial infarction (MI) was the admitting 
diagnosis in 32.6% of patients. Twenty-two percent of patients were diabetics, 
10.7% had pdor MI, 12.5% had congestive heart failure (CHF), 13.6% had 
prior PTCA and 9.8% had previous CABG. PTC, ~ was of a single vessel 
without intracoronaP/thmmbolysis in 82.8% of patients, of a single vessel 
with intracoronary thombolysis in 4.0% and was of multiple vessels in 11.7%. 
The average length of stay was 5.3 days and the average charge was 
$41,320 OvOrall moff~ltffy was 34% with ~gn~hcant ,rK~reases m moff~af~ 
for females (4.6% vs 28% in mates, p ,- 0,01), pat~m~ --62 y~ of age 
(46% v~ 15% in petient~ .62., p 001L Patmnt~ w~t,~ .ule MI as the 
admiP, ing d~agnosis (6,75% vs 1 8% m patmnt~ without ~¢ute MI, p ~ 0,01) 
an(l patients with CHF (li ,7% vs 2 ,~.  in patients wttt~0ttl CHF p ~ 0.01), 
In 1995 PO0 PTCAs were pertotmed in ~ o! the 146 (19,0%) m~!1~lon~ 
pedon'rmg PTCA The monal~y ~t PTGA m ins tnm~ ~ ~ 
¢~ m !995 wi~ 13,9% remitted to 33% in in~t~l~ns ~ ]~L:~0 
ca~es ip < 0,01) lt~t ye~r- 
~ n :  PTCA in Calltomi~ i~ ~ la le~ wlth ; ~  moflahly in 
women, 1!~ eldedy, peiti~lt~, admitted with I~ute MI, ~ ~lt~mts 
procedures am ped/o~ at lnstit~K~ns pedOrming less than ,200 PTCAs 
annually, 
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~ Pmdlct!n9 Moftlllly Following PTCA: Results From 
NCN " 
ED Petemon, D. Moore, LH  Muhlbaier, E.R DeLong, R, OresswalO. Duke 
Umv., Oumam, NC. USA 
~ br Few clinicat models e~mt that can accurately predqct mortalrty 
to, lowing percutaneous coronary ,nten~ent~n (PTCA) 
Mettles." We developed a PTCA mortality nsk prediction mode! hem 
the Natmnal Cardiovascular NetwOrk Database |n = 58,714 procedures per. 
formed at 19 U.S. centers between 1F34 Snd 1197) which used only oblactn~e 
climcal vanables. 
Resu/~s: Overall in-,bethel moflality rate was 12%. The maan ag~ was 
62.7 yrS. 32% were female. 24% had d~es  The significant mulhvanable 
p~ors  of in-hospital ~ i ty  am displayed below: 
RLSk FactOr" Ch* Sq OR 05% Ct 
Pre-~t~-'edtJre Can3K~gen~: F~t~ck 337 125 8 l - la  5 
LVEF (per 10% Oecline| 194 t 5 1 4--1 fi 
Pahent Age (pet 10~11~ o~Oerl t34 1 6 1 5--I 7 
Primary Ang~plasly fo~r Acute Mt 75 2 7 2 3-2 9 
BSA lO 1 dc~cl~'~e m meter?| 53 1 2 I 1-1 2 
Renal O~ase 26 2 3 ! 8-2 it 
Pncr ~¢cn=try |niefv~t~Ja 23 0 6 0 4-0 8 
Dtabet~ ~I ]~ 11 1 3 1 1-1 4 
Mutl~ves,~el Cofona~/O~sease 9 1 3 I 2-1 S 
PTe-PTCA IABP 6 1 6 1 1-2 0 
Proximal LAD De--ease 6 I 3 I I-I 5 
A~s~on MI (w/o PmnaP/PTCA) 5 1 3 I 1-1 6 
The rnoders overall dlscnn~nat/on abdity was excellent C-mdex = 0 813 
We internally validated the model usmg a bootstrap method tadjusted C-~ndex 
= 0 815). The model was also well cahbrated for prtidic1irlg outcomes in low- 
moderate- and htgh-nsk paSent groups 
Conc/usmn. This model repmseflts an accurate, oblectwe PTCA mortality 
r~k prediction ~1 which is useful for estimating patient outcomes and for 
~ lng  phys~ans wffh nsk-a~usted mortality results. 
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~ '~ Proteinuria in Diabetics is a Powerful Predictor of 
Death Following Percutaneous Coronary 
Revascularization 
S.P Marne. S.G. Elhs. R.E. Raymond, I. France, I~L. Whitlow, E.M. Tuzcu. 
E.J Topoi. C/e~etand Clinic Foundation, C/eve/arc/, Ohio, USA 
Background: Diabetics have a higher modality after percutaneous transcoro- 
naty revasculanzation (PTCR) than non-diabetics, but the etiology for this 
is poorly understood. We hypothesized if,at diabetics with proteinuna would 
have higher mortality than diabehcs w~thout proteinuna foll0~vin PTCR. ow- 
ing to an association of proteinuna and aCvanced atheroSctEmsis. 
MetMods: A total of =.537 consecutive diabebcs with unnalysis (UA) un- 
cle=went PTCR between 1/93 and 12/95 were d=vlded into preteinuna (pit),  
(n = 217) and non-preteinuna (non-pret) (n = 320) groups The prot group 
was fudher prospactwely d~nded into tow concentration (trace. 1+. 2+) and 
100 non- pmtmnuna 
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high concentration (3+, .3+) Moan follow-up time was 20 * 8.5 months, The 
pint and non.prot group8 differed with respect to moan LVEF (51 t 13,9, 
53 :( 12,81, numbor of diseased vossola (2,25 t 0,80, 2,01 ~ 0.83), insulin 
dependence (60 t 0,49, 34 ~ 0.47%) a~d serum crostlnlne (1,88 * 1.7, 1.14 
( 0,53 mg/dl) respectively. 
Results: Using multl-varlato Cox an~:lysis protoinurla iB an indopondont 
predictor of ov0nt-freo survival in our model (p .-. 0,03), 
Conc/uslon~: Protetnuria appoom to be a Blgnllicsnt prodlctor of mortality 
following PTCR, Fudhor, there nppenrs to boa "do~o response" such 1hat 
patients with high prototn wasting have a nearly 4 fold increase In 2 year 
mortality wllon compared to the non-prot ,aroup, 
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~3~ Chronic Rennl Failure Is Associated ILldependently 
With MortnUty After Succonful Percutaneoue 
Coronary Revasculorlzetlon 
H,H, Tlng, D, HaBdai, D,E, Grill, F.K. Tlmlmi, V. Mathew, D.R Holmes, J i ,  
Mayo Clinic, Rocho,'~ter, MN, USA 
Patients (pts) with chronic renal lalluro (CRF} undmgalng porcutannaus core. 
nary revn~cularlzallon (PCR) have greater rink of strife complications and 
roatenonls The effect of CRF on Iong-tnrm ontcoma after succoaslul PCR 
is not well-defined, PtB wl~o underwent successful PCR at Mayo Clinic be- 
tween 1903 and 1998 worn divided Into CRF (n ,, 1201, defined as c[oatinino 
.3.0 or en dialysis, and non.CRF (n = 2539), Mcaa follow.up time wan 1.2 
t 09 and 1,5 I 09 ynals for CRF and noa-CRF pts, respectlvoly. Stents 
were Implanted In ,19% of CRF and In 42% o! noa.CRF pts Mtdtlvarl~te 
Cox regression adiu~tia~, ! to~ clinlc~ll w~;iablo~ HIcludlag ago, hYl.!nrlOtl~ton, 
diabetes* mollltns, prior myocardial infarction, history el congestive heart fail. 
ure, porlphoral va.nc'ul,~r disease, metastatic cancer, and 3.vessel disease, 
showert that CRF 18 associated with Cncrosscd mo=lalily (relative risk 3,0, 
95% conltdonce tnfowal, 1.B ~'1,91, Kaplan-Maior anslys~8 showed that sur. 
vlvN taros worn 88,7",, and 84 7" .  in CRF and 08,5",, and 97,1% in non-CRF 
at B month and I year, respectively (p - 0.0g0t). At 1 year, Canadian Class 
3 or 4 engine was obsorved in 30% and 23.. of CRF and non-CRF pts, 
ronpocttvely (p =~ 007). 
Cortclu.qfons. Pts witl~ CRF are at greater risk of merry,lily after succo...slul 
PCR independently of other comorbidities: the maiority et deaths occurred 
within 0 months, CRF pts undergoing PCR should be cons=doted a high-risk 
subgroep, oven in the stoat ore 
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. a ,e , .o  C,.Ica, and A.g,ograp.,c Varied, .  and 
Long-term Outcome After Stent Implantation 
D.R. Holmes, Jr., C.S Rihal, P,B. Bergor, MR. Boll, K.N. Garraft Mayo 
Clinic. Roche.~te~ MN. USA 
Background: Long term results of stent implantation for discrete coronary 
stonotic lesions are not necessarily transl.~tablo to all pts or lesions being 
treated. This is ot particular impedance with concerns about instent roste- 
nosis and socioeconomic cost. Identification o! specihc clinical, lesional and 
angiographic factors associated with either better or worse long term outcome 
might improve pt slechon and optimize resource utilization. 
Methods: We evaluated long-form outcome in 1709 pts with successful 
stent implantation using a follow up combined adverse endpoint of death, 
repeat dilatation, coronary bypass surgery, or infarcbon. Thirteen clinical and 
18 angiographic variables, indication for steal, and number and size of stoats 
wore studied; the relationships between these variables and the combined 
ondpoint was assessed using multivariable analysis. The only significant 
variables were: 
Vanablo RL.~k R~ho 95°,. CI p 
P0or CABG 1 418 I1 134.1 773 0.002 
CHF Ever 14.14 {1 108, 1 881 0006 
MVD" 1 394 (1110.1.750 0.004 
Diabetes r 285 (1 010.1 635 0043 
LAD" 1 273 (1 026, 1 580 0028 
• muItivesse} disease: "left anterior do~;cending trealed 
Conclusions: There are easily identifiable characteristics which are as- 
sociated with worsened long-term outc: me. Stent placement rr,ay not be as 
beneficial in these pts as in pts roported in randomized trials. 
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~- ]  Stentln9 of Unprotected Left Main Coronary Artery 
Stenosls: Methodology, Stent Selection and Clinical 
Outcome 
R. Cortlno, J, Foiadof, B, Cassagnoau, C, Jordan, J,C. Lobordo, 
J.P, Lauront, 1". Joseph, J, Marco. Unite de Cnrdiologio Intetvenfionnelle, 
Clinique Pasteur, Toulouse, France 
Background; Slonting of unprotected Left Main Corenary Arton/ (LMCA~ 
ntonosiB has boon recently reported as an alternative fe sulgeq/for high 
surgical risk patients, 
Met,~od~; We report o,r experience in 57 conBooutwe pfs with prohibitive 
n(irgical risk who undcP,'vonf stooling e! unprotected LMCA, Them wore 
41t mnn and 9 women, moan ago 67.4 yearn (52~85), 40 unntablo ,"regina 
(70%), 6 AMI (11%), meatt LVEF = 56% (44-75), 63% throe vessel disease 
Moan LMCA stonosi~ was 73,7 ~ 11%, Methodology consisted on throe 
dsyn pretroatmont will1 aspiring 250 mglday and ttc!Opidino 500 rag!day, 
except in thn 6 pts treated for AML The procedure was performed under 
='lourolopt analgesia, via transfomoral and trannradial approach in 32 and 25 
pts re~poctlvelv, with extrasuppart guido wires, short balloon inflations (mean 
39.2 nee), high balloon presot.o 1o1 predilalaf=on (moon 14.6 aim) and for 
ntent implantation (163 aim) IABP was used in only 2 pls and rotational 
ablation in 5 pin IVUS was (rot used in any case, 
FIe~ults Stoat selection based on anatomical characfonstics of the LMCA 
lesion wa~ as loUnwa: 31 coil (GR II, Cressllow) stents tot LMCA bilurcahon 
with LAD ot LCx, 17 slotted tube (Palma,~-Schatz) stoats for osttal and mid 
LMCA lesions and 11 cellular (GFX, NIR) designed stents for nil type of 
lesion8 Procedural success was achieved in all pin with a moan final stenl 
diameter = 392 ~ 0.6 mm. Clinical outcome Is displayed in the following 
table: 
Clinical outcome 11'1.ho.'~01(~11 t3 month-FU 
Non (~(t,~l MI O 0 
Repent LMCA PTCA 0 1 
CABG o t 
Clvetall IIIollahty .1 (7"..) 5 (a 4"ol 
Cardiac dearth 3 (5 2%) 4 17 5%l 
Corrclus~on: With ngorous methodology and apprepnate stent selection, 
unprotected LMCA stontmg can be performed with high procedural success 
rate and low in-hospital major cardiac events rate Mid-term outcome can be 
considered acceptable taking into account the poor prognosis of this high 
risk population. 
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[-8-~-] "Idiopathic" Ventrlcular Tachycardia is Not Really 
Idiopathic, Structural Ventricular Abnormalities 
Detected by Positron Emission Tomography 
ED. Engelstein. SG Sawada. GD. Hutchins. S. Straka. R. Sehra. 
R.L. Fain, R. Amaravadi. W.M. Miles. D.P. Zipes. Indiana University Medical 
Center, Indianapohs. hrdiana. USA 
Patients with idiopathic ventricular tachycardia (VT) by definition have no 
known structural heart disease and normal left ventricular (LV) function 
by cardiac catheterization and echocardlography. However, abnormalities 
in myocardial innerva'.ion and metabolism may be present and be patho- 
physiologically impodant. Positron Emission Tomography (PET) studies of 
myocardial blood flow using nitrogen-13 ammonia (NH3) were performed in 
12 pts (36 ~ 9 yrs, 4 male) with idiupathic monomorphic VT o~nlirmed by 
electrophysiologic study; five of these pts also had PET using f!ugdne-,~ 
fluorodeoxyglucose (FDG) for glucose metabolism; the other ; pts had PET 
scans of sympathetic innervatton with carbon-t1 hydroxyephedrine (HED). A 
semi-automated program was used to determine NH3 and FDG uptake and 
HED retention in 177 regions of interest encompassing the LV myocardium. 
Peffusion, metabolism and innervation defects were defined as the percent 
of LV with tracer uptake or retention greater tllan 2 SD below values obtained 
from a database of normal controls. Small pedusion defects were detected 
in 6/12 pts ranging from 1-9%, mean for the whole group 2 ± 3%. However, 
FDG defects were seen in 5/5 pts, mean 9 4 27% (range 1-37%) and HED 
defects were observed in 5/7 pts, mean 8 ~ 9% (range ?-21%) The extent 
of HED and FDG defects exceeded that of the NH3 defects in all but one pt. 
